41
John O McWeeney, Benjamin E Morris, David W Robertson, David I Freed, James F Schuerman, John B Golden, Jozef Slanda, Brian Keith Wells, Jesse Leonard Farris III, Michael S H Chu, Oscar R Carrillo Jr, Todd A Hall, Yem Chin, Mark L Adams: In-vivo visualization system. Boston Scientific Scimed, Bookoff McAndrews PLLC, December 17, 2013: US08608649 (1 worldwide citation)

Several embodiments of the present invention are generally directed to medical visualization systems that comprise combinations of disposable and reusable components, such as catheters, functional handles, hubs, optical devices, etc. Other embodiments of the present invention are generally directed ...


42
Christopher Oskin, Isaac Ostrovsky, David W Robertson, Michael Barenboym: Steering mechanism. Boston Scientific Scimed, Bookoff McAndrews PLLC, September 16, 2014: US08834357 (1 worldwide citation)

A steering mechanism is used as part of a medical device such as a catheter or an endoscope to allow movement of a steerable distal portion of the catheter or endoscope. The mechanism can include a elongate housing adapted to be coupled to the steerable portion of the medical device and an actuation ...


43
Marlene L Cohen, David W Robertson: Substituted cyclo or bicycloalkylamides of (8.beta.)-6-(substituted) ergolines. Eli Lilly and Company, Robert D Titus, April 14, 1998: US05739146 (1 worldwide citation)

The present invention provides (8.beta.)-N-substituted cyclo or bicycloalkyl-6-(substituted)-ergoline-8-carboxamides useful for occupying 5HT.sub.2 or 5HT.sub.1.sbsb.c receptors in mammals. The invention also provides methods for treating a variety of disorders and conditions related to or affecting ...


44
David W Robertson, David T Wong: 1-Phenylalkylamines as selective serotonin uptake inhibitors. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, October 24, 1989: US04876282 (1 worldwide citation)

The present invention provides 1-phenyl-(naphthalenyl)alkylamines which are selective inhibitors of serotonin uptake.


45
David W Robertson: Flexible endoscope with modifiable stiffness. Boston Scientific Scimed, Bookoff McAndrews PLLC, November 12, 2013: US08579802 (1 worldwide citation)

An apparatus includes a flexible elongate member that defines a lumen and is configured to be inserted within a body passageway of a patient. The flexible elongate member includes a proximal portion, a distal portion, and a medial portion disposed between the proximal portion and the distal portion. ...


46
David W Robertson: Anticonvulsant agents. Eli Lilly and Company, Robert A Conrad, Leroy Whitaker, November 27, 1990: US04973597 (1 worldwide citation)

This invention provides certain pyridinecarboxamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.


47
David W Robertson: Inotropic agents. Eli Lilly and Company, Leroy Whitaker, Arthur R Whale, August 6, 1985: US04533734 (1 worldwide citation)

This invention provides for certain imidazo compounds, their pharmaceutical formulations, and their use as positive inotropic agents, bronchodilators, vasodilators, and anticoagulants.


48
David W Robertson, Michael F Weiser, Kevin L Newell, John Petricca: Boston Scientific Scimed, Brake Hughes Bellermann, January 6, 2015: US08926636 (1 worldwide citation)

In some embodiments, an apparatus includes a handle and an elongate member coupled to the handle. The elongate member has a first portion, a second portion and a third portion. The first portion of the elongate member extends from the handle and defines a first longitudinal axis. The second portion ...


49
Robert B McCall, Robert Clyde Marshall, David W Robertson, Thomas M Ashley: Treating fibromyalgia and chronic fatigue syndrome. Pharmacia & Upjohn Company, Austin W Zhang, September 10, 2002: US06448258 (1 worldwide citation)

The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds or a salt of any said compound.


50
Robert B McCall, Robert Clyde Marshall, David W Robertson, Thomas M Ashley: Compounds for treating fibromyalgia and chronic fatigue syndrome. Pharmacia & Upjohn Company, Austin W Zhang, April 29, 2003: US06555548 (1 worldwide citation)

The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of cabergoline-type compounds or a salt of said compound.



Click the thumbnails below to visualize the patent trend.